New York City plans to distribute Johnson & Johnson’s single-dose COVID-19 vaccine to its senior residences once the vaccine maker receives approval for emergency use authorization. Johnson & Johnson has pledged to provide 20 million doses of its single-dose COVID-19 vaccine by the end of March.
“The big piece we want to get to is the literally in-home vaccination of folks who cannot leave their home — that really requires the Johnson & Johnson vaccine,” Mayor Bill de Blasio said.
“We will be ready very rapidly to do door-to-door in-home vaccinations for in-bound seniors over the month,” Dave Chokshi, City Health Commissioner, said.
Johnson & Johnson is waiting for the FDA to give it emergency authorization use.
“We hope in March if everything goes according to plan with the FDA and to do that based on the supply allocated by the federal government,” Chokshi said.
According to the New York Post, Dr. Richard Nettles from Johnson & Johnson said four million doses of the shot are ready to ship now.
“We will have 20 million doses of the vaccine available by the end of March, and we’re prepared to ship immediately upon emergency authorization four million doses of the vaccine,” Nettles said.
There is a strong interest in Johnson & Johnson’s vaccine because it is single-dose, and it’s easier to store than the other COVID-19 vaccines.